News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Antonio Giordano: Benefit of CDK4/6i in HER2+ MBC
Antonio Giordano/X
May 20, 2025, 10:09

Antonio Giordano: Benefit of CDK4/6i in HER2+ MBC

Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X:

“More evidence of the benefit of CDK4/6i in HER2+ MBC seen in a phase 2 study of TD-M1 plus Palbociclib.
 Palbociclib benefit was independent of ER status when combined to TD-M1.”

Antonio Giordano shared results from a phase 2 study evaluating the combination of TD-M1 and Palbociclib in HER2-positive metastatic breast cancer. The findings suggest that the clinical benefit of Palbociclib was not influenced by estrogen receptor status.

Antonio Giordano: Benefit of CDK4/6i in HER2+ MBC

More posts featuring Antonio Giordano.

Antonio Giordano cancer CDK4/6i Dana-Farber Cancer Institute ESMOBreast2025 fight against cancer Global fight against cancer global fight against cancerCancer HER2 MBC MedOnc metastatic breast cancer OncoDaily Oncology palbociclib TD-M1
Special Coverage
Blog
May 20, 2025, 17:22
The Lancet Group's Editorial Team Will Be on the Ground at ASCO 2025
Blog
May 20, 2025, 17:11
Pam Traxel: One in Ten Cancer Survivors Rely on Medicaid - Cuts Have Consequences
Blog
May 20, 2025, 16:58
Elvina Majiwa and Murallitharan Munisamy Have Won The World No Tobacco Day Award - UICC
Blog
May 20, 2025, 16:56
PER Tumor Board: Applying Recent Advances to Transform the Treatment Paradigm in SCLC
Blog
May 20, 2025, 16:46
Shahrin Ahmed: Specific Pre-surgery Medication Improves Survival Rates in Hereditary Breast Cancer Cases
Blog
May 20, 2025, 16:43
Ahmed Magdy Rabea: Pleased to Give a Multiple Myeloma Awareness Session to the Pfizer Egypt Team
Blog
May 20, 2025, 16:37
Sachin Jain: The Greatest Impact of AI Will Come from Improving Care and Service
Blog
May 20, 2025, 16:27
It Is Time to Invest in Cancer Research - Stand Up To Cancer
Insight
May 20, 2025, 15:50
Oliver Bogler Announced the Launch of the NanCI AI Webapp for Scientific Literature and Networking
Blog
May 20, 2025, 15:37
Fumiko Ladd Chino: Even with Superlative Healthcare You Can Still End Up with Stage 4 Cancer
Blog
May 20, 2025, 15:20
Save the date for the 7th CCI4EU Online Course - "Early Cancer Detection, Screening, and Prevention"
Insight
May 20, 2025, 15:05
New JCO Oncology Practice Piece on Debunking Myths of Hope in Cancer Care